ÂÜÀòÂÒÂ×

Mélanie Liron is a highly experienced professional in the pharmaceutical and biotechnology sectors, currently serving as a Senior Global Programme Manager at Debiopharm since September 2022. Prior to this role, Mélanie held various positions at UCB, including Early Drug Development Global Program Manager and Late Stage Drug Development Global Program Manager, with a focus on immuno-oncology and neurology. Mélanie's experience also includes consultancy roles at Avertim, Cenexi LT, Greater Paris University Hospitals, and Utopies, and significant project management and R&D contributions at Pall Life Sciences. Mélanie holds a Ph.D. in Organic Chemistry, an Executive MBA in Marketing and Sustainable Development, and has a strong educational background in chemical engineering.